Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients

BACKGROUND: Thromboembolic disease is a frequent cause of death during SARS CoV-2 infection. Lupus anticoagulant (LA) appears frequently during the acute phase of infection. It is not clear whether it is merely an epiphenomenon or whether it is related to the patients' outcome. METHODS: Prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Constans, Mireia, Santiago, Raquel, Jimenez, Lidia, Motllo, Cristina, Lopez, Rosario, Trapé, Jaume, Reverter, J. Carlos, Altes, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539822/
https://www.ncbi.nlm.nih.gov/pubmed/34743034
http://dx.doi.org/10.1016/j.thromres.2021.10.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539822/
https://www.ncbi.nlm.nih.gov/pubmed/34743034
http://dx.doi.org/10.1016/j.thromres.2021.10.017

Ejemplares similares